fda food and drug administration news

FDA Approves 1st New Schizophrenia Drug in Decades

FDA Approves the First New Schizophrenia Drug in Decades

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.

Investopedia on MSN · 1h

Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval

Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.

Yahoo · 8m

The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the debilitating mental disorder in over seven decades.

FDA issues recall notices for two brands of pet food

YAHOO!News · 19h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

USA TODAY on MSN · 1d

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

Fox Business on MSN · 2d

Pet food recalled over possible salmonella, listeria contamination

Dog food sold online and in stores is being recalled after tests conducted by federal health officials revealed the presence of both listeria and salmonella.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 20h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 19h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 21h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

Medscape30m

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

14h

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

FDA approves new kind of drug for schizophrenia

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...

1hon MSN

US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results